Affirm Holdings, Inc. (AFRM)
收市後：
| 前收市價 | 32.08 |
| 開市 | 30.85 |
| 買盤 | 31.62 x 600 |
| 賣出價 | 31.65 x 600 |
| 今日波幅 | 30.27 - 32.08 |
| 52 週波幅 | 8.80 - 52.48 |
| 成交量 | |
| 平均成交量 | 8,421,775 |
| 市值 | 9.713B |
| Beta 值 (5 年，每月) | 3.58 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.49 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 37.05 |
Barrons.comWalmart-Backed Fintech Dives Into BNPL. It’s a Rival to Affirm.
One, a fintech largely owned by Walmart, has started to advertise its buy now, pay later options in the company’s stores.
Investor's Business DailyDown On Its Luck Affirm Stock Gets Bearish Customer News
Affirm stock wavered Tuesday amid a report that Walmart, a key customer of the consumer financing firm, is readying its own "buy now, pay later" services.
ReutersBuy now, pay later lender Affirm pushes into elective medical procedures
Fintech lender Affirm has started quietly offering "buy now, pay later" (BNPL) loans for elective medical procedures, in a major push beyond its core e-commerce market, the company told Reuters. Over the past year, Affirm has more than doubled the number of elective medical merchants on its network, reaching around 130 at of the end of 2023. The San Francisco-based company is hoping to tap growing consumer demand for financing for cosmetic treatments, dental services, medical devices and veterinary procedures.
